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Abstract
Although airway patency is partially maintained by parenchymal tethering, this structural support is often ignored in many
discussions of asthma. However, agonists that induce smooth muscle contraction also stiffen the parenchyma, so such
parenchymal stiffening may serve as a defense mechanism to prevent airway narrowing or closure. To quantify this effect,
specifically how changes in parenchymal stiffness alter airway size at different levels of lung inflation, in the present study,
we devised a method to separate the effect of parenchymal stiffening from that of direct airway narrowing. Six anesthetized
dogs were studied under four conditions: baseline, after whole lung aerosol histamine challenge, after local airway
histamine challenge, and after complete relaxation of the airways. In each of these conditions, we used High resolution
Computed Tomography to measure airway size and lung volume at five different airway pressures (0, 12, 25, 32, and 45 cm
H2O). Parenchymal stiffening had a protective effect on airway narrowing, a fact that may be important in the airway
response to deep inspiration in asthma. When the parenchyma was stiffened by whole lung aerosol histamine challenge, at
every lung volume above FRC, the airways were larger than when they were directly challenged with histamine to the same
initial constriction. These results show for the first time that a stiff parenchyma per se minimizes the airway narrowing that
occurs with histamine challenge at any lung volume. Thus in clinical asthma, it is not simply increased airway smooth
muscle contraction, but perhaps a lack of homogeneous parenchymal stiffening that contributes to the symptomatic airway
hyperresponsiveness.
Citation: Brown RH, Kaczka DW, Mitzner W (2010) Effect of Parenchymal Stiffness on Canine Airway Size with Lung Inflation. PLoS ONE 5(4): e10332. doi:10.1371/
journal.pone.0010332
Editor: Neeraj Vij, Johns Hopkins School of Medicine, United States of America
Received December 10, 2009; Accepted February 25, 2010; Published April 26, 2010
Copyright:  2010 Brown et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health (NIH) research grant HL-10342. The funder had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wmitzner@jhsph.edu
Introduction
It has been suggested that the loss of protection normally offered
by a deep inspiration against augmented airway narrowing in
asthmatic subjects reflects an intrinsic pathophysiology of this
disease [1,2,3,4,5]. Although it seems clear that properties of
airway smooth muscle must be involved in this functional
difference, the properties of the parenchyma that surround the
airways also may play an important role. Parenchymal tethering
produces a transmural load on the airways that depends on both
the distensibility of the lung (bulk elastic modulus) and its ability to
deform (shear modulus) [28]. With lung inflation, both of these
variables increase. Thus, if the parenchyma is stiffened, for a given
level of lung inflation, the distending forces on the airways will be
increased relative to the baseline state. There is good evidence that
parenchymal stiffness is increased with agonists that cause smooth
muscle contraction, and several investigations have emphasized
the potential importance of the parenchyma in asthma [6,7,8].
Experimental studies in animal models and human studies clearly
show that methacholine can stiffen the lung parenchyma,
increasing both elastance and tissue resistance [9,10], and these
changes will affect the airways under both static and dynamic
conditions. They also suggest that the abnormal response in
asthma to a deep inspiration may be related to the interaction
between airway smooth muscle and its stiffened parenchymal
environment. This stiffer lung surrounding the airway may also
serve as a protective response during an asthma attack by limiting
airway narrowing or closure, but this hypothesis has not been
evaluated. One reason for this lack of knowledge is that the ability
to directly measure and separate the effect of parenchymal
stiffening on the airway caliber has not been available. In the
present study, we have designed an in vivo protocol that allows
separation of the effect of airway contraction with and without
stiffened parenchyma at different lung volumes. This protocol
compares a whole lung aerosol challenge that contracts airways
and stiffens the parenchyma with local challenges via a
bronchoscopically-guided catheter that contracts only individual
airways. Results show for the first time that a stiff parenchyma per
se minimizes the airway narrowing that occurs with airway smooth
muscle constriction at any lung volume.
Methods
The study protocol was approved and signed by The Johns
Hopkins Animal Care and Use Committee, with the officially
approved protocol #DO08H03. All handling of the animals from
anesthesia to recovery were done in strict accordance with the
guidelines presented in both the Public Health Service Policy on
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Laboratory Animal Welfare, National Institutes of Health,
Bethesda, MD) and the Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources Commission
on Life Sciences, National Research Council, Washington, DC).
Six dogs weighing approximately 20 kg were anesthetized with
pharmaceutical grade thiopental sodium (15 mg/kg induction
dose followed by 10 mg/kg/hr intravenous maintenance dose). A
stable depth of anesthesia was monitored by lash reflex, heart rate,
and respiration, and airway pressure and end tidal CO2 are
measured and used to assess the adequacy of ventilation. After
induction of anesthesia, the dogs were paralyzed during the
imaging with 0.5 mg/kg of succinylcholine to ensure no
respiratory motion. Following endotracheal intubation with an
8.0 mm ID endotracheal tube, the dogs were placed supine and
their lungs were ventilated with room air using a volume-cycled
ventilator (Harvard Apparatus, Millus, MA) at a tidal volume of
15 ml/kg and a rate of 18 breaths/minute. In four of the dogs, we
inserted a thin-walled latex esophageal balloon inflated with
0.8 ml of air which was positioned in the lower third of the
esophagus to estimate pleural pressure changes [11]. Transpul-
monary pressure (Ptp) was measured as the difference between the
airway pressure measured at the end of the endotracheal tube and
the esophageal pressure. Following the experimental procedures
all animals were kept under direct observation until they were
breathing normally. The investigators and/or a trained technician
remained as long as necessary to ensure that no animal received
less than adequate monitoring until they had fully recovered from
the anesthesia and exhibit normal behavior.
Protocol
Each dog served as its own control. The dogs were anesthetized
and ventilated as described above. They were studied under four
conditions on 2 separate days at least 2 weeks apart, in random
order. The four conditions were studied on two separate days. On
one of the days we measured the following: 1) baseline diameter
and volume with no exogenous challenge; and followed by 2)
measurements after total lung challenge with aerosolized hista-
mine. On the other day we measured: 3) the lungs and airways
after relaxation with atropine; and then followed by 4) measure-
ments after a local histamine challenge to 5 or 6 selected airway
segments of less than 1 cm in length [12]. To standardize lung
volume history, prior to the first High Resolution Computed
Tomography (HRCT) scan series, the airway pressure was
increased to 45 cmH2O, held for 5 seconds and then released,
followed by normal ventilation.
On one experimental day, baseline HRCT scans were acquired
(details below), followed by an aerosol challenge of histamine
(200 mg/ml, 5 breaths to 15 cm H2O, Sigma Chemical, St Louis
MO). The aerosol challenges were administered by a Hudson
3000 nebulizer (Hudson, Temecula, CA) driven by compressed
oxygen at 10 L/min. Under test conditions with an operating
pressure of 50 psi and a flow rate of 10 L/min, the nebulizer
produced particles of mass median diameter of 3.1 mm with a
geometric SD of 3.2. Given such a relatively dispersed particle size
distribution, good central and peripheral distribution should have
been achieved [13]. Approximately 1 mL of solution was delivered
by the nebulizer during this whole lung challenge. Three minutes
later, the HRCT scans were acquired.
Onthesecondexperimentalday,intravenousatropine(0.2 mg/kg)
was administered, a dose previously shown to completely block
vagal tone in the dog [14]. After 10 minutes, relaxed airway scans
were acquired. A second method of airway constriction was done
by local atomization of agonist delivered directly to the epithelium
of the same airway locations that were measured during the
aerosol challenge. The atomization was accomplished with a
specially designed catheter that could be placed with broncho-
scopic visualization [12]. This catheter consisted of PE-190 tubing
with a short (2-mm) plastic tube inserted into the tip. This tube had
six tiny (0.15-mm) side holes drilled circumferentially 1 mm from
the end, and the end was plugged with a 1-mm stainless steel rod.
This metal plug aided visualization in the computed tomography
(CT) scanner. In practice, the catheter was filled outside the lung
with the desired agonist concentration and advanced 1.5 cm
beyond the tip of the bronchoscope. Rapid injections of 20 mL
boluses caused the liquid to be sprayed radially on the adjacent
airway wall, with minimal axial spread [12]. Five to six airways
were identified in each dog and challenged with histamine (20 mL
per bolus per airway, concentration: 200 mg/ml, Sigma Chem-
ical, St Louis MO). The histamine dose was chosen based on pilot
studies on nonexperimental days. It took between 15–20 seconds
to challenge the 5 or 6 airways. All airway locations to be
challenged were identified prior to the deep inspiration to set
volume history. For the local challenges, the ventilator was
stopped, a single dose was administered to each of the 5 or 6
airway locations over 15–20 seconds, the bronchoscope was
removed, and normal ventilation was resumed. After 3 minutes,
ventilation was stopped for the HRCT scan acquisition. For each
condition on both experimental days, the airway sizes and lung
volumes were measured at 5 airway pressures in increasing order:
0, 12, 25 32, and 45 cm H2O. Each scan series took approximately
8 seconds to complete. The dogs were ventilated normally between
scanning.
Imaging and Analysis
HRCT scans were obtained with a Sensation-16 scanner
(Siemens, Iselin, NJ) using a spiral mode to acquire approximately
300 CT images during an 8 second breath hold (apnea) at 137
kVp, and 165 mA. The total lung volumes (apex to base) were
scanned. The images were reconstructed at 1 mm slice thickness
with a 512x512 matrix using a 230 mm field of view and a high
spatial frequency (resolution) algorithm that enhanced edge
detection, at a window level of -450 Hounsfield units (HU) and
a window width of 1,350 HU. These settings have been shown to
provide accurate measurement of luminal size as small as 0.5 mm
in diameter [15,16]. For repeated airway measurements in a given
dog within each experimental protocol, adjacent anatomic
landmarks, such as airway or vascular branching points, were
used to locate and measure the airway area at the same anatomic
cross sections. Representative images used for this quantitative
analysis are shown later in the second Results panel.
Airway area on the HRCT images was analyzed using the
airway analysis module of the Volumetric Image and Display
Analysis (VIDA) image analysis software package (Dept. of
Radiology, Division of Physiologic Imaging, Univ. of Iowa, Iowa
City, IA) as previously described and validated [14,17]. The
HRCT images were transferred to a UNIX-based Sun worksta-
tion. An initial isocontour was drawn within each airway lumen,
and the software program then automatically located the
perimeter of the airway lumen by sending out rays in a spoke-
wheel fashion to a predesignated pixel intensity level that defines
the luminal edge of the airway wall. From the airway area (A) thus
determined, mean airway diameter was calculated as 2(A/p)
1/2.
Intra- and inter-observer accuracy and variability of the software
program using this HRCT technique in phantoms, consisting of
rigid tubes to measure known areas, has been previously shown by
us [15] and by others [17] to be highly resistant to operator bias.
After segmentation of the parenchyma from the chest wall and
Parenchyma and Airways
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calculated by summing the volume of individual voxel elements
contained within the region of interest using the Pulmonary
Workstation 2 software (VIDA diagnostics, Iowa City, IA).
Data Analysis:. To compare the airway sizes at baseline and
after relaxation with atropine, we analyzed the data using a
standard least squares model with airway diameter as a percent of
maximum as the outcome variable and airway pressure, the
condition (baseline or after atropine), and lung volume as a
percentage of maximum as the independent variables. Also, the
Tukey HSD correction for post hocmultiple comparisons was used.
To comparethe airwaysize afterhistamine challenge by the aerosol
route to the airway size after the catheter route, we analyzed the
data using a standard least squares model with airway diameter as a
percent of maximum as the outcome variable and airway pressure,
the route of challenge (aerosol or catheter), and lung volume as a
percentage of maximum as the independent variables again with
the above Tukey HSD correction. To compare the lung volumes
after histamine challenge by the aerosol route to the catheter route,
we used one-way ANOVA. In addition, we also analyzed the
change in transpulmonary pressure using a standard least squares
model with the transpulmonary pressure as the outcome variable
and lung volume as a percentage of maximum, pressure, and the 4
conditions as the independent variables. Significant difference were
assumed if the p-value was ,0.05.
Results
In each dog, the same individual airways were matched and
measured on the separate days with the different challenges. In
four dogs, we were able to match six airways, and in the other two
dogs we matched five airways. These 3
rd-4
th generation airways
ranged in size from 3.9 to 10.5 mm in diameter at baseline and
were in both the right and left lungs. In order to compare results
from these different sized airways, individual airway diameter was
normalized to a maximum defined as the diameter of the airway
after smooth muscle relaxation at 45 cm H2O airway pressure. At
baseline or when relaxed with atropine, the airways behaved
similarly to increased lung volume or inflation pressure (Figures 1A
and 1B), with no significant differences in mean airway diameter at
any lung volume or airway pressure above functional residual
capacity (FRC) (12 cm H2O, 25 cm H2O, 32 cm H2O and 45 cm
H2O( P .0.05). At FRC, there was a significant difference between
the airway size at baseline (75.0%65%, mean6SEM) compared
to after relaxation 83.0%62%, P,0.05), indicating the presence
of baseline tone.
With increased smooth muscle tone caused by whole lung
histamine aerosol challenge, the mean airway size at FRC was
43.6%65%. For the local direct airway challenge, the mean
airway diameter at FRC was 32.0%67% after challenge, but this
was not significantly different from the airway size after aerosol
challenge at FRC (P.0.05, Figure 1A). We also analyzed the
data using a paired analysis (t-test) on the airway size (%
maximum) at FRC by dog (n=6), and this analysis also showed
no statistical difference (p=0.08).
Although the airways started out with the same degree of
narrowing regardless of the method of stimulation, there were
significant differences in how they responded to increasing
inflation pressure, depending on the how the histamine was
delivered. At airway pressures of 12, 25, and 32 cm H2O, the
airways were larger after aerosol challenge than after the local
challenge (P,0.05). At 45 cm H2O, again there was no difference
in the airway size (P.0.05, Figure 1B). In addition, at 45 cm
H2O, mean airway diameter was only 87.0%66% and
76.1%67% of maximum for the aerosol and locally challenged
airways, respectively, indicating that even at the maximal inflation
airways were still not fully dilated with either challenge. Figure 2
shows representative HRCT images from one animal at three
pressures with either the local catheter or whole lung aerosol
challenge. Two airways identified by the arrows are seen in all the
images. These qualitative images show a similar size at the lowest
and highest pressures, but a clearly smaller size with the catheter
stimulation at the midrange pressure as quantified in Figure 1.
Lung volume at FRC (0 cm H2O) was not different among the
four conditions (P.0.05). At baseline or after atropine, lung
volume expanded to a similar extent (P.0.05) at each airway
pressure. However, when airway smooth muscle tone was
increased by histamine, the lung volume expanded a smaller
amount for each increase in airway pressure compared to the
condition without histamine (P,0.05). There were also significant
differences in lung volume between the aerosol and catheter
challenges. As might be expected, the global aerosol challenge
caused a greater stiffening of the lung. At 25 cm H2O (P=0.02)
and 32 cm H2O (P=0.04) this stiffer lung resulted in volumes that
were significantly smaller after the aerosol challenge than after the
catheter challenge. At 12 cm H2O and 45 cm H2O, however, the
difference in lung volume was not significant.
Figure 3 shows the mean lung volume as a function of
transpulmonary pressure in the four dogs where we measured
esophageal pressure. As expected, transpulmonary pressure
increased significantly with airway pressure (p,0.0001) in all four
states, and there were no differences in transpulmonary pressures
among the four states at any fixed level of airway pressure
(p=0.21).
Figure 4 shows the cube of the mean airway diameter vs. the
mean lung volume. This graph scales the airway size to the same
dimensions as the lung volume. After histamine challenge, at all
lung volumes above FRC, this scaled airway was significantly
greater (p,0.001) with the aerosol challenge than with the local
challenge.
Discussion
Parenchymal tethering produces a distending stress on the outer
surface of airways, and with lung inflation, that stress increases. If
lung volume is constant, any stiffening of the parenchyma should
therefore lead to an increase in this distending stress on the airways
relative to the baseline state with no exogenous contraction. The
results of this study show that such parenchymal stiffening caused
caused by generalized contraction of the entire airway tree does
indeed have a protective effect on airway narrowing. When the
parenchyma was stiffened by whole lung aerosol histamine
challenge, at every lung volume above FRC, the airways were
larger than when they were directly challenged with histamine to a
similar initial constriction. These results are not a result simply of
an increased lung volume, since at every increase in lung inflation
above FRC, the lung volumes were significantly smaller with the
global aerosol histamine compared to the local histamine
challenge. If we had tried to compare airway diameters at
matched lung volumes, then the airway size with the whole lung
challenge would have been even greater.
Before continuing further discussion of possible mechanisms
and implications, it is important to consider why the parenchyma
stiffens when a smooth muscle agonist is administered. If we
consider the parenchyma to mean the alveoli and alveolar walls,
then there is little there that could result in a stiffer lung after
histamine challenge. While contractile interstitial (Kapanci) cells
have been described in the lung [18], these are generally only
Parenchyma and Airways
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10332Figure 1. A: The mean (6SEM) airway diameter (as a percentage of the maximum airway diameter) vs. the mean (6SEM) lung volume (as a
percentage of the maximum lung volume) at each airway pressure (0, 12, 25, 32, and 45 cm H2O) under the four conditions: baseline (before aerosol,
open squares), atropine (before catheter, open triangles), aerosol histamine challenge (black squares), and individual airway catheter challenge (black
triangles). B: The mean (6SEM) airway diameter (as a percentage of the maximum airway diameter) vs. the mean airway pressure under the same
four conditions. There were significant differences in airway diameter and lung volume between the aerosol and catheter challenges. At every airway
pressure above 0 cm H2O the airways were larger after aerosol challenge than after the local challenge (see text). Also, the aerosol challenge caused a
greater stiffening of the lung. (*) At every airway pressure above 0 cm H2O, the lung volumes were larger after the catheter challenge than after the
aerosol challenge (see text for p-values).
doi:10.1371/journal.pone.0010332.g001
Parenchyma and Airways
PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10332Figure 2. Representative HRCT images at three pressures with either the local catheter or whole lung aerosol challenge. Two
individual airways identified by the arrows are seen in all the images. The airway sizes at 0 and 45 cm H2O appear similar with either challenge, but at
25 cm H2O, the airways with the catheter stimulation are clearly smaller than with the aerosol challenge.
doi:10.1371/journal.pone.0010332.g002
Figure 3. The mean (±SEM) lung volume (as a percentage of the maximum lung volume) and transpulmonary pressure (cm H2O) at
each airway pressure (0, 12, 25, 32, and 45 cm H2O) under the four conditions: baseline (before aerosol, open squares), atropine
(before catheter, open triangles), aerosol histamine challenge (black squares), and individual airway catheter challenge (black
triangles) among four dogs. Transpulmonary pressure increased significantly with airway pressure (p,0.0001) in all four states, and there were no
differences in transpulmonary pressures among the four states at any fixed level of airway pressure (p=0.38).
doi:10.1371/journal.pone.0010332.g003
Parenchyma and Airways
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effect on lung elasticity. Increased tone in the pulmonary blood
vessels could have an effect on lung stiffness [19], but vascular
smooth muscle does not contract with histamine. So, any increased
lung stiffness must result entirely from contraction of airway
smooth muscle, which exists in all airways down to the acini [20].
It is not known how much of the change in lung stiffness results
from large or small airway constriction, but it is known that
restricting the contractile agonist to just the conducting airways
supplied by the bronchial circulation can cause a significant
increase in lung elasticity [21]. In addition to stiffening the lung,
smooth muscle contraction also results in increased tissue
resistance [22]. Thus, when a whole lung agonist challenge is
administered, not only are the airways narrowed, but there is also
a stiffer, more viscous lung tissue [23]. These considerations
highlight the fact that the airway tree cannot normally be
separated from the parenchyma, since acute changes in paren-
chymal elasticity depend entirely on changes in airway smooth
muscle tone, an idea that has been around for almost 100 years
[24]. Our present results as shown in Figure 1B demonstrate for
the first time that the converse is also true, i.e., that a stiffer
parenchyma makes the airways stiffer as well. This effect is greatest
at lung volumes close to FRC, and it progressively diminishes as
lung volume approaches TLC.
Such a stiffened parenchyma as occurs with whole lung aerosol
challenge acts as an increased elastic load on the airways that
reduces the degree of narrowing. In contrast, when just a few
airways are challenged directly through the catheter, without
contraction of the rest of the airway tree, the parenchyma does not
provide this increased load to attenuate the airway narrowing in
vivo. These results support the concept that a stiffer lung tissue acts
as a protective mechanism to minimize airway narrowing. We also
observed that at the maximum lung inflation, the size of the
airways after the aerosol challenge compared to the catheter
challenge were not different (Figures 1A and B). This observation
suggests that this protective effect on airway narrowing is limited,
and that it can be overcome if the lung is inflated to sufficiently
high volume.
Our conclusions, however, do not agree with several published
studies [25,26,27]. Okazawa, et al concluded that in an excised
rabbit lung the tethering effect of the lung parenchyma was not
significantly increased by airway smooth muscle contraction. In
interpreting their data, they used a continuum mechanics model of
this interaction [28], where the bulk elastic modulus reflects the
distensibility of the lung and the shear modulus (m) reflects the
ability of the lung to distort. The larger the shear modulus the
smaller would be the change in airway diameter, and since m is
directly proportional to Ptp [29], an increased lung volume would
also lessen the airway diameter changes. Okazawa et al [25] found
that in a rabbit lung, carbachol had minimal effect on m, with a
small increase only at a Ptp of 12 cmH2O. We are not sure exactly
how to account for this difference from our work, but we do note
that our significant changes occurred at a Ptp range from <15 to
35 cmH2O, whereas Okazawa, et al made their measurements at a
pressure range below 16 cmH2O. It is also unclear how these
experimental studies fit with the theoretical modeling of Lambert
and Pare ´ [25,26,27], where it was concluded that the role of the
parenchyma would only be effective at low lung volume.
Figure 4. The relation between mean (±SEM) lung volume (as a percentage of the maximum lung volume) and mean (±SEM) airway
diameter cubed. Both variables were measured at the five airway pressures (0, 12, 25, 32, and 45 cm H2O) under the four conditions: baseline
(before aerosol, open squares), atropine (before catheter, open triangles), aerosol histamine challenge (black squares), and individual airway catheter
challenge (black triangles). Airway diameter cubed is substantially and significantly less dependent on lung volume with the local catheter challenge
significantly with airway pressure (p,0.001) at all lung volumes above FRC (0 cm H20 Paw).
doi:10.1371/journal.pone.0010332.g004
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examined in vivo with intact parenchyma, and in vitro with the
parenchyma removed. They found no differences in airway
narrowing at various transpulmonary pressures whether the
parenchyma was intact or removed. In addition, there was no
effect of cholinergic stimulation, and they thus concluded that
parenchymal tethering is relatively unimportant in maintaining
airway size. However, it is important to note that pig airways have
a key structural difference from most other species, that being an
unusually large amount of cartilage in their airwaywalls that can
physically prevent severe narrowing [30]. This limitation was
manifested in the study by Noble et al by the relaxed pig airway
pressure-diameter curves, which were shown to be relatively flat
and linear, and lacking the sharp knee at low pressure as seen in
our Figure 1B.
There is, however, one potential explanation of our results that
could be consistent with the weak parenchymal effects as found in
these two studies. If one assumed that there was substantial airway
closure with the aerosol challenge, then at the same total lung
volume, a smaller fraction of the lung would be inflated and this
would require a higher Ptp for this fraction. This higher Ptp would
give rise to an increased shear and bulk modulus, and this would
lead to increased airway size. We cannot rule this mechanism out,
except to say that we have not seen any evidence of such closure in
canine lung, at least down to the resolution of HRCT (<1mm). If
airway closure occurred in even smaller airways and was extensive
enough over the whole lung, it could possibly account for our
findings.
The results of this study also confirmed previous findings related
to airway distension with lung inflation [14]. In that study, when
the airways were either at baseline or relaxed, increasing airway
pressure quickly led to a maximal size similar to what we showed
in Figure 1B. This supports the notion that with minimal smooth
muscle tone, canine airways are very distensible structures. When
airway smooth muscle has increased tone, then the response to
lung inflation depends on the degree of tone and the properties of
the surrounding parenchyma. Increasing lung volume to a
predicted lung capacity (i.e., at Ptp<37 cmH2O) was not sufficient
to fully dilate the airways, regardless of how the tone was
generated. At TLC, mean airway diameters were only 87.0% and
76.1% of maximum for the aerosol and locally challenged airways
respectively (Figure 1B). This was also the case in humans,
where, with increased smooth muscle tone, airway size remains
attenuated at TLC [14].
In comparing the two modes of challenge, there is one further
difference that could possibly play a role. With the aerosol
challenge, it was necessary to inflate the lung to deliver the
aerosol, whereas the local challenge was delivered at FRC. It is
known that both ventilation and deep inspiration can transiently
decrease the airway responsiveness to an agonist challenge
[1,2,3,31,32,33,34,35], so it is possible that the decreased response
to the aerosol challenge resulted from the delivery procedure. We
attempted to minimize this potential effect by delivering the
aerosol in only five breaths at a modest peak pressure of 15 cm
H2O, which is only slightly above normal ventilation pressure at
end inspiration. This is also much lower than the conventional
Mch challenge procedure used to document hyperresponsiveness
in asthmatic subjects, i.e., that of inhaling the agonist to TLC and
holding one’s breathe for 5 seconds. Our protocol here was in fact
similar to the protocol for prevention of deep breaths to evaluate
bronchoprotection and bronchodilation with just tidal volume
breathing [1,2,3,36]. In addition, we waited 3 minutes after each
challenge, ventilating the dogs with the same normal tidal volume
breaths as used after the local catheter challenge, before acquiring
the first set of scans at FRC. We therefore feel that this mechanism
was unlikely to be playing a major role in our observations.
The results in this study offer a possible explanation of a
previously reported puzzling observation. We showed that with a
high enough local dose of agonist, airways could be constricted to
closure, and could not always be opened even at high lung
volumes [12,37]. This observation is at odds with many whole lung
challenges where closure of large airways is not seen. Our present
results offer a possible solution to this controversy, since without
the parenchymal stiffening that occurs with whole lung challenge,
it is easier for an individual airway to reach a smaller size even
down to complete closure.
Finally, while induced bronchoconstriction by bronchial
challenge is only a diagnostic and research tool for asthma, we
offer a speculation about the potential clinical ramification of our
observations. In clinical asthma, whether or not there is an
inflammatory component, the final common pathway is airway
smooth muscle contraction, and often enough the strength of this
constriction may be greater than that which lung inflation can
overcome. While not experimentally tested during an acute
asthma attack, experimental studies with induced bronchocon-
striction in asthmatic patients clearly show the inability of a deep
inspiration to restore airway size [38,39,40,41]. Thus, in clinical
asthma, it is not simply increased airway smooth muscle
contraction, but perhaps a lack of homogeneous parenchymal
stiffening that contributes to the symptomatic airway hyperre-
sponsiveness [23]. Heterogeneous airway narrowing could be
detrimental in asthma, since such heterogeneity could mimic the
effect we observed with the direct localized airway stimulation. In
either case, decreased parenchymal tethering forces could account
for the loss of bronchoprotection and bronchodilation seen in
asthma and COPD with emphysema [1,42].
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